Replies to post #47078 on Avid Bioservices Inc (CDMO)

[cjgaddy]

Nuke, you're 100% right! Maybe he STILL IS C.R. - that'd be totally incredible in that class of Adv./Metastatic Lung cancer patients. But, I don't think it's likely, since there's been no further ref. to that one C.R. after the 2-4-2009 PR.

I'm really looking FWD to the initial data on Stage2 (n=28), but I think we'll have to wait till ASCO to get it.

= = = = = = = = = = = = =
D. Ph.2 Bavi+CP vs. Adv./Met. LUNG Cancer (NSCLC) - INDIA:
http://clinicaltrials.gov/ct2/show/NCT00687817 (21+28=49)
1st-DOSED: 6-30-08 => 80.1wks a/o 1-12-10
ALL-21-ENROLLED-Stage1: 10-20-08 => 64.1wks a/o 1-12-10 (1.3/wk)
1st-DOSED-Stage2(28): 4-20-09 => 38.1wks a/o 1-12-10
ALL-28-DOSED-Stage2: 10-5-09 => 14.1wks a/o 1-12-10 (1.2/wk)
******> S2-EST a/o 1-12-10: Should have all 28 at 12wk-scans(3 of 6 3wk cycles), and ~22 at 18wk-scans(6 of 6 3wk cycles).

Bavi+CP-BREAST/India: 6 4wk-cycles of chemo, weekly-bavi (no prior chemo/immuno/rad)
http://clinicaltrials.gov/ct2/show/NCT00669565